On November 8th, 2023, the FDA approved Eli Lilly and Co.’s new weight loss drug, Zepbound. This approval comes amid a growing shortage of semaglutide-based drugs, such as Ozempic and Wegovy, which are commonly prescribed “off-label” for... Read More
In a recent advisory opinion, the United States Department of Health and Human Services Office of Inspector General (the “OIG”) appears to reaffirm its previous findings concerning the compliance of certain practices by online healthcare... Read More
Previously, we outlined New York Governor Kathy Hochul’s proposed 2023-2024 New York State Budget (“Proposed Budget”) and how it may impact the healthcare deal landscape in New York. Specifically, we discussed proposed amendments to Part L of... Read More
In the rapidly evolving landscape of healthcare, small and medium-sized home healthcare providers play a crucial role in delivering quality care to individuals in need. As home healthcare continues to provide better access, improve outcomes and save... Read More
Recently, New York Governor Kathy Hochul unveiled the 2023-2024 budget for New York State (the “Budget”), including an amendment to Part L of the Health and Mental Hygiene Article VII (the “Proposed Legislation”). The Proposed Legislation... Read More
On January 5, 2023, the Federal Trade Commission (“FTC”) issued a Notice of Proposed Rulemaking (the “Notice”) containing a proposed rule (“Rule”) that would restrict employers from entering into and/or enforcing non-compete agreements... Read More
Effective as of November 16, 2022, certain health care entities must continue to employ certain employees for a period of four months following a change in control of such entity. On August 18, 2022, New Jersey Governor Phil Murphy signed Public... Read More
